Who Owns Elementis Company?

GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Elementis

Full Company Analysis:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

Who controls Elementis plc?

Elementis plc has faced activist pressure from Franklin Mutual Advisers and Odyssean Capital in 2024–2025, pushing for a sale to unlock value. Institutional investors now largely determine strategy versus management’s Innovation-to-Growth plan.

Who Owns Elementis Company?

Ownership is concentrated among institutional asset managers and activist funds; stakes and voting dynamics drove calls for strategic change in 2024–2025, affecting capital allocation and governance. See Elementis Porter's Five Forces Analysis.

Who Founded Elementis?

Harrisons & Crosfield was founded in Liverpool in 1844 by Daniel Harrison, Smith Harrison and Joseph Crosfield; initial ownership was a private partnership split by capital and role, focused on tea and coffee brokerage before pivoting to rubber and palm oil in Southeast Asia.

Icon

Founding partners

Daniel Harrison, Smith Harrison and Joseph Crosfield established the firm in 1844 as Harrisons & Crosfield in Liverpool.

Icon

Initial ownership model

Equity was allocated via a traditional private partnership based on capital contributions and operational roles.

Icon

Family control

The Harrison family retained the primary equity stake and executive control through the mid-19th century.

Icon

Investment sources

Capital was raised through friends-and-family networks of Liverpool and London merchants rather than public markets.

Icon

Strategic shift

The firm shifted emphasis to rubber and palm oil plantations in Southeast Asia, aligning ownership with long-term asset accumulation.

Icon

Path to public markets

By the early 20th century the company floated to finance large plantation acquisitions, while partnership culture and internal promotion endured.

Ownership evolved from partnership seniority and familial succession into a public corporate structure by the 1900s, with no venture-style vesting; the Elementis identity emerged after late 20th-century restructuring, reflecting that historical arc.

Icon

Founders and early ownership — key points

Core facts about early Harrisons & Crosfield ownership and governance.

  • Founded in 1844 in Liverpool by Daniel Harrison, Smith Harrison and Joseph Crosfield.
  • Initial structure: private partnership with equity split by capital and role.
  • Harrison family held primary equity and executive control into the mid-19th century.
  • Transitioned to a public company in the early 20th century to fund plantation expansion, preserving partnership culture.

For context on later corporate evolution and competitors, see Competitors Landscape of Elementis.

Complete Elementis Strategy Bundle

  • 6 Full Frameworks, 1 Company – All Pre-Researched
  • Each Framework Fully Sourced with Real Company Data
  • Built for Strategy Courses, Case Studies & MBA Programs
  • Adapt to Your Assignment – No Starting from Scratch
  • 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
Get Related Template

How Has Elementis’s Ownership Changed Over Time?

The divestment of commodity units and the 1998 rebranding shifted Elementis ownership from conglomerate investors to specialist institutional fund managers; by FY2024 institutional holders held nearly all equity, and post-2023 strategic disposals accelerated concentration of control. Key events: 1998 rebrand, progressive spin-offs, the $170,000,000 2023 Chromium sale, and targeted portfolio refocus on Personal Care and Performance Specialties.

Year / Event Ownership Impact
1998 Rebranding and strategic pivot Shift from diversified conglomerate shareholders to specialist institutional investors
2023 Chromium divestment ($170,000,000) De-leveraging driven by institutional pressure; reinforced focus on higher-margin specialty segments
FY2024 disclosures Institutional concentration near 100% of free float; top 10 hold > 55%

Institutional consolidation altered Elementis corporate structure and governance dynamics: concentrated stakes enable coordinated influence over board appointments, M&A approvals and capital allocation, and have tightened performance expectations around margins and cash conversion.

Icon

Major institutional stakeholders (2025)

Top holders combine passive and activist strategies; ownership data sourced from SEC filings and UK regulatory disclosures through 2025.

  • Schroders PLC — approximately 10.1% voting rights
  • Franklin Mutual Advisers — approximately 9.8% voting rights
  • BlackRock Inc. — approximately 5.7% stake
  • Odyssean Capital — approximately 4.2% stake
  • Columbia Threadneedle Investments — material institutional holding (reporting in 2025)

Regulatory filings indicate the top ten shareholders control over 55% of outstanding shares, concentrating power for strategic decisions; for further context on market positioning and investor targeting see Target Market of Elementis.

From PESTLE Factors to Full Strategy Bundle

  • PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
  • Every Strategic Angle Covered – Nothing Left to Research
  • Pre-filled with Company-Specific Research
  • No Missing Sections for Your Case Study
  • One Download Covers Your Entire Company Analysis
Get Related Template

Who Sits on Elementis’s Board?

Elementis plc's Board of Directors is chaired by John O'Higgins with Paul Waterman as Chief Executive; the board comprises eight members, a majority of whom are independent non-executive directors in line with the UK Corporate Governance Code, supporting one-share-one-vote governance and transparent shareholder accountability.

Director Role Relevant expertise
John O'Higgins Chair Corporate governance, board leadership
Paul Waterman Chief Executive Chemicals, strategy, operational leadership
Independent NEDs (5) Non-Executive Directors M&A, finance, industry experience

The company adheres to a one-share-one-vote structure, so voting power equals economic interest, and no golden shares or veto rights exist; institutional investors and activist funds thus play decisive roles during contested proxy seasons.

Icon

Board dynamics and voting power

Recent proxy seasons in 2024–2025 saw activist engagement reshape board composition and strategy, prompting targeted non-executive appointments with M&A and chemicals expertise.

  • One-share-one-vote: voting proportional to ownership
  • Institutional alignment amplifies influence of funds
  • Activists like Giam and Franklin Mutual pressed for formal sale processes
  • Board added NEDs to strengthen M&A and industry knowledge

Institutional investors constitute the largest segment of Elementis shareholders; at year-end 2025, top institutional holdings collectively represented an estimated ~55% of issued shares, intensifying pressure on the board to balance internal growth plans with calls for value realization; see Mission, Vision & Core Values of Elementis for related corporate context.

Elementis Business Model + Strategy Bundle

  • Ideal for Essays, Case Studies & Slides
  • Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
  • Company-Specific Content Already Organized
  • One Bundle Replaces Days of Independent Research
  • Buy the Bundle Once. Use Across All Your Assignments
Get Related Template

What Recent Changes Have Shaped Elementis’s Ownership Landscape?

Over 2023–2025 Elementis ownership has trended toward consolidation, with activist interest and private equity scrutiny intensifying amid continued share-price discounting versus specialty-chemical peers.

Year Key ownership / corporate event Impact
2023 Institutional accumulation; ESG-focused funds increase stakes Pressure to rebalance portfolio away from talc; governance scrutiny
2024 Completion of efficiency programme delivering 20,000,000 annual cost savings Improved free cash flow but persisting valuation gap vs peers
Early 2025 Private equity consortia reported evaluating the company Take-private speculation rises due to strong FCF and hectorite market position
Late 2025 Executive departures; public target margin: 17% by 2026 Signals potential ownership transition or strategic sale/divestment

Institutional holders have increasingly lobbied for divestment of the Talc business, which generated approximately 140,000,000 in revenue in 2024, citing litigation exposure and a desire for a purer specialty-chemicals profile; analysts cite persistent rumors about a take-private deal and note that Elementis ownership concentration, activist engagement, and executive turnover raise the probability of a strategic merger or private equity buyout.

Icon Valuation gap vs peers

Elementis shares have traded at a discount to peers such as Croda and Ashland despite improved margins from cost saves.

Icon Private equity interest

Multiple PE consortia reviewed Elementis in early 2025, attracted by stable free cash flow and a leading position in hectorite clay additives.

Icon Institutional ESG pressure

ESG-aligned institutional investors have pushed for talc divestment and a clearer specialty-chemicals strategy to reduce litigation exposure.

Icon Management turnover

Departures of several long-tenured executives in 2025 point to a governance and ownership inflection that could precede a sale or restructuring.

For additional context on Elementis revenue composition and how ownership decisions tie to business lines, see Revenue Streams & Business Model of Elementis

From Five Forces to Full Company Analysis

  • Includes SWOT, PESTLE, BMC, BCG and 4P's
  • Pre-Researched with Company-Specific Data
  • Best Value for a Complete Analysis
  • Ready to Adapt for Your Case Study
  • Ready for Essays and Slidesd
Get Related Template

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.